
Sign up to save your podcasts
Or


Sunil Dhaliwal founded Amplify in 2012, and was joined by his longtime friend and colleague Mike Dauber in 2014. Beginning as one of the first solo GP, early-stage, sector-focused funds, Amplify has now grown to a team of 9 partners investing in the next generation of applications tools and platforms for developers, data teams, and ML engineers focused on AI, cloud infrastructure, and data security. Mike and Sunil sit down with Beezer Clarkson, Partner at Sapphire Partners, to discuss their strategy of building for outliers, shaping founders into leaders, and making it easy for their GPs to back non-consensus companies. They also unpack their recent $900 million raise and their first dedicated biotech fund, Amplify Bio.
Learn more about Sapphire Partners: https://sapphireventures.com/sapphire-partners
Learn more about OpenLP: https://openlp.vc
Learn more about Asylum Ventures: https://asylum.vc
Learn more about Amplify: https://amplifypartners.com
For a monthly roundup of the latest venture insights, including the newest Origins episodes, subscribe to the OpenLP newsletter – delivered straight to your inbox: subscribe.openlp.vc
CHAPTERS:
0:00 Welcome to Origins
2:17 The Origins of Amplify
5:21 Eliminating the Need for “Mr. Business”
10:25 Building Amplify for Outliers
25:08 Being Technical VCs in the Age of AI
28:47 Amplify Bio
36:19 Has Venture Actually Changed At All?
By OpenLP from Sapphire Partners4.6
6464 ratings
Sunil Dhaliwal founded Amplify in 2012, and was joined by his longtime friend and colleague Mike Dauber in 2014. Beginning as one of the first solo GP, early-stage, sector-focused funds, Amplify has now grown to a team of 9 partners investing in the next generation of applications tools and platforms for developers, data teams, and ML engineers focused on AI, cloud infrastructure, and data security. Mike and Sunil sit down with Beezer Clarkson, Partner at Sapphire Partners, to discuss their strategy of building for outliers, shaping founders into leaders, and making it easy for their GPs to back non-consensus companies. They also unpack their recent $900 million raise and their first dedicated biotech fund, Amplify Bio.
Learn more about Sapphire Partners: https://sapphireventures.com/sapphire-partners
Learn more about OpenLP: https://openlp.vc
Learn more about Asylum Ventures: https://asylum.vc
Learn more about Amplify: https://amplifypartners.com
For a monthly roundup of the latest venture insights, including the newest Origins episodes, subscribe to the OpenLP newsletter – delivered straight to your inbox: subscribe.openlp.vc
CHAPTERS:
0:00 Welcome to Origins
2:17 The Origins of Amplify
5:21 Eliminating the Need for “Mr. Business”
10:25 Building Amplify for Outliers
25:08 Being Technical VCs in the Age of AI
28:47 Amplify Bio
36:19 Has Venture Actually Changed At All?

1,293 Listeners

536 Listeners

1,096 Listeners

340 Listeners

796 Listeners

233 Listeners

147 Listeners

9,956 Listeners

448 Listeners

134 Listeners

512 Listeners

37 Listeners

41 Listeners

1 Listeners

49 Listeners